"CRISPR Therapy Shows Promise in HIV Cure Trials"

The search for a cure for HIV continues, with CRISPR gene editing technology showing promise. Chinese scientists have used CRISPR to edit the CCR5 gene in an HIV patient, but further research is needed to achieve complete eradication of the virus. Excision BioTherapeutics has started a clinical trial for its CRISPR-based drug, EBT-101, which targets three sites within the HIV genome. Challenges in finding a cure include the rapid mutation and resistance of the virus, as well as safety concerns and the need for long-term studies. While a CRISPR-based therapy may take time to become widely available, it offers a promising solution for developing a curative treatment for HIV.